➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Mallinckrodt
Baxter
Medtronic

Last Updated: November 29, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DROSPIRENONE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Drospirenone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00102141 Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women Completed Bayer Phase 3 2004-04-01 The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8 weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the relief of vasomotor symptoms and who have hypertension.
NCT00185419 A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception Completed Bayer Phase 3 2003-11-01 The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women
NCT00185484 Efficacy and Safety Oral Contraceptive Study Completed Bayer Phase 3 2004-03-01 The purpose of this study is to determine whether the study drug is effective in prevention of pregnancy in healthy women in reproductive age
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Drospirenone

Condition Name

Condition Name for Drospirenone
Intervention Trials
Contraception 29
Polycystic Ovary Syndrome 10
Healthy 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Drospirenone
Intervention Trials
Polycystic Ovary Syndrome 12
Syndrome 12
Dysmenorrhea 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Drospirenone

Trials by Country

Trials by Country for Drospirenone
Location Trials
United States 162
China 48
Germany 48
Japan 29
United Kingdom 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Drospirenone
Location Trials
Pennsylvania 10
California 9
Florida 8
Arizona 7
Washington 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Drospirenone

Clinical Trial Phase

Clinical Trial Phase for Drospirenone
Clinical Trial Phase Trials
Phase 4 18
Phase 3 38
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Drospirenone
Clinical Trial Phase Trials
Completed 57
Recruiting 14
Unknown status 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Drospirenone

Sponsor Name

Sponsor Name for Drospirenone
Sponsor Trials
Bayer 38
Estetra 8
Catholic University of the Sacred Heart 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Drospirenone
Sponsor Trials
Industry 68
Other 36
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Dow
Moodys
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.